The newly authorized drug Zanvastro treats the rare genetic condition by suppressing toxic protein buildup.
Live Poll
Should government prioritize funding for research into rare diseases over relying on private fundraising efforts?
October 7, 2026
Dementia Diagnosis Reduced End-of-Life Treatment SupportAdults were 19 percentage points less likely to suggest life-sustaining care for dementia patients in recent survey data.
October 7, 2026
Researchers Cultured Human Brain Organoids for Five YearsA new long-term study reveals how human cortical organoids mature over years of development in the lab.
October 7, 2026
Parkinson's Drug Candidate Showed Early Promise in TrialA new oral treatment for Parkinson's disease demonstrated potential for improving neurological function and biomarkers.
October 6, 2026
Aspirin Use Linked to Bruising ConcernsUnderstanding how common blood-thinning medications can influence your skin health.
October 6, 2026
Chronic Pain Linked to Brain Health in Former PlayersFormer football players using certain medications for pain reported higher rates of neurobehavioral issues in a 2026 study.
October 6, 2026
FDA Approved New Parkinson's Drug JuvmoAdults with Parkinson's may soon have a new daily pill option to manage symptoms.
October 6, 2026
Researchers Have Advanced CTE Diagnosis ToolsNew diagnostic tests aim to identify chronic traumatic encephalopathy in living patients for the first time.
October 6, 2026
Stable Midlife Employment Boosted Later Cognitive HealthInconsistent employment history in midlife may negatively impact memory and executive function scores as you age.
October 6, 2026
Parkinson's Monitoring Platform Joined athenahealth NetworkClinicians can now use an FDA-cleared remote tool to track movement symptoms through the athenahealth ecosystem.
October 6, 2026
Williams Family Reactivated Late Actor's InstagramThe family of Robin Williams hopes to protect his digital likeness from unauthorized AI use.
